Nationwide Fund Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-7,743
Closed -$23K 3226
2016
Q3
$23K Hold
7,743
﹤0.01% 3114
2016
Q2
$20K Sell
7,743
-21,445
-73% -$59.8K ﹤0.01% 3149
2016
Q1
$86K Buy
29,188
+11,007
+61% +$58.9K ﹤0.01% 2873
2015
Q4
$149K Hold
18,181
﹤0.01% 2689
2015
Q3
$130K Buy
18,181
+511
+3% +$4.26K ﹤0.01% 2792
2015
Q2
$162K Sell
17,670
-1,362
-7% -$13.1K ﹤0.01% 2817
2015
Q1
$180K Sell
19,032
-130
-0.7% -$1.25K ﹤0.01% 2743
2014
Q4
$186K Sell
19,162
-327
-2% -$3.29K ﹤0.01% 2669
2014
Q3
$186K Hold
19,489
﹤0.01% 2726
2014
Q2
$256K Buy
19,489
+1,185
+6% +$14.9K ﹤0.01% 2628
2014
Q1
$243K Buy
18,304
+740
+4% +$9.74K ﹤0.01% 2403
2013
Q4
$171K Buy
17,564
+293
+2% +$2.76K ﹤0.01% 2761
2013
Q3
$170K Buy
17,271
+10,993
+175% +$109K ﹤0.01% 2740
2013
Q2
$57K Buy
+6,278
New +$65.8K ﹤0.01% 2934

Other funds holding CDMO

Nationwide Fund Advisors's CDMO Position: Q4 2016 in Review

Nationwide Fund Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2016, closing a stake of 7,743 shares — an estimated $23K sold.

Nationwide Fund Advisors first reported a position in CDMO in Q2 2013 and held it in 14 quarters. The position peaked at $256K in Q2 2014. 67 funds tracked by Wall St. Rank hold CDMO as of Q4 2016.

  • Nationwide Fund Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Nationwide Fund Advisors sold 7,743 Avid Bioservices, Inc. Common Stock shares in Q4 2016, an estimated $23K.
  • Nationwide Fund Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 14 quarters.
  • Nationwide Fund Advisors's Avid Bioservices, Inc. Common Stock position peaked at $256K in Q2 2014.
  • 67 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2016.

Based on Nationwide Fund Advisors's 13F filing for Q4 2016, filed 27 Jan 2017.